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S U M M A R Y
Mediterranean spotted fever (MSF) is caused by Rickettsia conorii and transmitted by the brown dog tick
Rhipicephalus sanguineus. It is prevalent in southern Europe, Africa and central Asia.
The disease usually has a benign course and is characterized by fever, myalgia and a characteristic
papular rash with an inoculation eschar (‘tache noir’) at the site of the tick bite. Severe forms of disease
can have cardiac, neurologic or renal involvement. Nervous system complications are unusual and may
develop in the early phase of disease or as a delayed complication. Neurological symptoms include
headache and alterations of the level of consciousness, and some cases of meningoenchefalitis and
Guillain-Barre` syndrome have been also reported. Peripheral nerve involvement is reported only in a
limited number of case reports.
We describe a case of Rickettsia conorii that was complicated with hearing loss and did not respond to
speciﬁc treatment. Hearing loss is a rare event, but clinicians should be aware of this complication.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Mediterranean spotted fever (MSF), also known as boutonneuse
fever, is a zoonosis caused by Rickettsia conorii and is occasionally
transmitted to humans through the bite of an infected tick
(Rhipicephalus sanguineus).
It is a member of the spotted fever group of rickettsiae and it is
widely distributed throughout southern Europe, Africa, and the* Corresponding author. U.O. Ematologia non tumorale e coagulopatie Fonda-
zione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico, Dipartimento di
Fisiopatologia Medico-Chirurgica e dei Trapianti, Address: Via Sforza 28, 20122,
Milan, Italy. Tel.: +39 02 5503 5320; fax: +39 02 55034722.
E-mail addresses: raffa.vale@tin.it (R. Rossio), valeria.conalbi@studenti.unimi.it
(V. Conalbi), V.castagna92@gmail.com (V. Castagna),
Sebastianorecalcati@hotmail.com (S. Recalcati), Adriana.torri@policlinico.mi.it
(A. Torri), coen.massimo@hsacco.it (M. Coen), lucia.restano@fastwebnet.it
(L.R. Cassulini), ﬂora.peyvandi@unimi.it (F. Peyvandi).
http://dx.doi.org/10.1016/j.ijid.2015.04.005
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Middle East. In Italy the most affected region is Sicily. Most cases
occur during the period from July to September, when the tick
vectors are active.
Diagnosis is often made with the following symptoms: fever, a
popular and purpuric skin rash involving palms and soles, and a
black eschar (tache noire) that can be found at the site of the thick
bite and represents local endothelial invasion by rickettsiae.
Severe forms of the disease have been reported, especially in
adults with the following conditions: diabetes, cardiac disease,
chronic alcoholism, glucose-6-phosphate dehydrogenase deﬁciency,
end-stage renal kidney disease. Another relevant factor is prior
prescription of delayed and/or inappropriate antibiotic.1
Diagnosis of the disease is based on epidemiologic, clinical and
laboratory criteria. Doxycycline is considered the drug of choice.
Neurological manifestations described in the literature are rare,
and the most common are encephalitis and Guillain–Barre´
syndromes.2 Rarely has the involvement of peripheral nerve also
been reported.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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complicated by irreversible hearing loss.
2. Case Report
In September 2014, a 74-year-old Italian woman was admitted
to the Ospedale Maggiore Policlinico in Milan, Italy, because of high
fever, diarrhea, arthralgia and a cutaneous rash that persisted for
seven days. She had returned a week before from holiday in Sicily,
South Italy. Her medical history included: hypertension, type II
diabetes mellitus and dyslipidemia.
On examination, the patient showed a non-itching maculo-
papular rash most notably on the trunk, also involving her legs and
arms, and the remaining physical examination was unremarkable.
Laboratory tests revealed a pathological value for C-reactive
protein (20 mg/dl normal value < 0,5 mg/dl), mild neutrophil
leucocytosis (white blood cell count 10,2 X 10 9/l, 80% polymor-
phonuclear neutrophils), and abnormal liver function tests
(alanine aminotransferase 64 IU/l and aspartate aminotransferase
51 IU/l). The chest x- ray was normal.
Blood, stool and urine samples were sent for culture analysis.
An empiric antimicrobial agent, ceftriaxone 2 g/day was prescribed
without improvement, and meanwhile the cutaneous rash
worsened.
On her third day of hospital stay, the dermatological picture of
the patient was characterized by a widespread maculopapular rash
with palmoplantar involvement. The lesions were pink, blanchable
macules of 3-5 mm in diameter, evolving over a few days to mildly
inﬁltrated papules sometimes with a purpuric or haemorragic
aspect. An erythematous, indurated lesion with a diameter of
12 mm with a central necrotic eschar was found on the posterior
aspect of her right leg (Fig. 1).
A careful re-evaluation of the patient’s history revealed that she
had gone trekking in the woods during her vacation in Sicily. Based
on clinical symptoms, history, and laboratory results, a diagnosis ofFigure 1. Erythematous papules with purpuric aspects disseminated on patient’s trunk Mediterranean spotted fever was made and treatment with
doxycycline 100 mg twice a day was started ten days after the
onset of symptoms. After the administration of doxycycline, fever
subsided and inﬂammatory values started to decrease, the skin
rash gradually resolved and her general conditions were improved.
Unfortunately, three days after the admission, the patient
complained about her hearing.
She had no vertigo or tinnitus, both tympanic membranes were
observed intact on otoscopy. The audiometric test showed a proﬁle
of right anacusis without any vocal discrimination, and a mild
sensorineural hypoacusis on acute tones involving the left ear.
Magnetic resonance imaging examination of the brain revealed
phlogistic bilateral impairment of the mastoid, most pronounced
on the right side, and a barrier alteration involving cochlea on the
right side suggesting a meningogenic relevance. Auditory evoked
potentials conﬁrmed sensorineural hearing loss.
Therefore the otolaryngologist recommended adding citicoline
and hyperbaric oxygen therapy to the ongoing treatment. The
patient was discharged with a diagnosis of Mediterranean spotted
fever, receiving doxycycline for a total of nine days.
Treatment with citicoline, steroids and hyperbaric oxygen
therapy were started, but subsequent to eight sessions she had no
improvement. On the tenth day after discharge the patient ended
the therapy with citicoline and steroids. Later, the patient
underwent eight sessions of oxygen therapy. In November the
audiometric test after the sixteenth cycles did not show any
improvement in her hearing impairment.
An immunoﬂuorescent antibody test was performed two
months after the onset of symptoms, showing elevated IgM and
IgG titers to Ricketsia conorii (IgG titer:1: 4000 [normal value <
1:64] and IgM titer 1:512 respectively [normal value < 1:16]). The
serological tests were consistent with a recent infection of R.
conorii.
Currently, three months after the acute infection, the patient
has an irreversible hearing loss.(A) Palmar involvement (B). Detail of the tache noire at the site of the mite bite (C).
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In this report we presented a case of a typical MSF with hearing
loss, a rare neurological complication. The patient had the typical
clinical features of Mediterranean spotted fever, with fever, a
characteristic maculopapular and purpuric rash with palmoplantar
involvement, and the presence of ‘the tache noire’, the small eschar
representing the site of the tick’s bite, which is the cutaneous
hallmark of this disease. Headache, myalgia and diarrhoea were
present.
Neurological involvement in rickettsial infections is described
in a minority of reported cases with severe systemic manifesta-
tions. Meningoenchefalitis, myelitis, Guillain-Barre` syndrome and
facial nerve paralysis also have been reported.3
Rickettsioses are systemic diseases with symptoms caused by
vasculitis, which results from proliferation of rickettsiae in
vascular endothelial cells. Direct rickettsial invasion of the nervous
system has been described in patients with acute neurological
complications, but subacute involvement of rickettsiosis is
believed to be secondary to immune-mediated mechanisms,
because also Guillan-Barre` polyneuropathy has been described
after infection with Rickettsia conorii and Rickettsia rickettsii.4
Cases of hearing loss related to rickettsial diseases have been
more rarely described in the literature. Hearing loss can be
unilateral or bilateral and can be a long term sequela as in Rocky
Mountain spotted fever or a transient alteration. One third of
patients with scrub typhus are known to develop deafness, which
is considered to be a diagnostic feature. Rare association between
murine typhus and hearing loss is documented. Only a case of
transient subacute hearing loss associated with Ricketssia conorii is
described.5
In our patient hearing loss was a delayed complication and we
have not observed an improvement using doxycycline, steroid
therapy and hyperbaric oxygen therapy. The few cases reported in
the literature showed that antibiotic therapy is necessary, whereas
use of corticosteroids is a controversial treatment.To our knowledge, this is the ﬁrst case of nonreversible hearing
impairment in a patient with rickettsial infection. The reemer-
gence of rickettsial infections is occurring in many regions of the
world due to human travel and environmental changes, thus
clinicians should know the complications related to the disease.
This case emphasizes the importance of considering Mediterra-
nean spotted fever in the differential diagnosis of a patient with
fever and rash, especially in people with a history of travel in
endemic areas.
A prompt diagnosis is fundamental since early antibiotic
treatment signiﬁcantly improves the outcome of the disease.
Moreover in this report we want to underline the importance of
neurological complications in patients with rickettsial infection.
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MSF= Mediterranean spotted fever.
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